Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer ...

FRIDAY, Dec. 13, 2024 (HealthDay News) -- A “watch-and-wait” strategy might be the best option for some women with ...

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

When a woman learns she has breast cancer , her reaction is often: take it out. Now doctors say that might not always be ...

For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...

ACTIVE monitoring may be a safe and effective treatment option for patients with low-risk ductal carcinoma in situ (DCIS), ...

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients ...

Metastatic breast cancer diagnoses are rising in U.S. women, especially in younger age groups and racial minorities, as ...